DK166654B1 - THE CONTACT LENS CLEANING SITE WITH TWO TREATMENTS - Google Patents

THE CONTACT LENS CLEANING SITE WITH TWO TREATMENTS Download PDF

Info

Publication number
DK166654B1
DK166654B1 DK431286A DK431286A DK166654B1 DK 166654 B1 DK166654 B1 DK 166654B1 DK 431286 A DK431286 A DK 431286A DK 431286 A DK431286 A DK 431286A DK 166654 B1 DK166654 B1 DK 166654B1
Authority
DK
Denmark
Prior art keywords
contact lens
kit according
lens cleaning
cleaning kit
enzyme catalyst
Prior art date
Application number
DK431286A
Other languages
Danish (da)
Other versions
DK431286A (en
DK431286D0 (en
Inventor
Gerhard Ludwig
Horst Schaefer
Rainer Sunderdiek
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK431286D0 publication Critical patent/DK431286D0/en
Publication of DK431286A publication Critical patent/DK431286A/en
Application granted granted Critical
Publication of DK166654B1 publication Critical patent/DK166654B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L12/00Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
    • A61L12/08Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
    • A61L12/12Non-macromolecular oxygen-containing compounds, e.g. hydrogen peroxide or ozone
    • A61L12/124Hydrogen peroxide; Peroxy compounds
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11DDETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/0005Other compounding ingredients characterised by their effect
    • C11D3/0078Compositions for cleaning contact lenses, spectacles or lenses

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Eyeglasses (AREA)
  • Catalysts (AREA)

Description

DK 166654 B1DK 166654 B1

Opfindelsen angår et kontaktlinserensesæt med to hehandlings-midler, hvoraf det ene er et steriliserende hydrogenperoxid, og det andet er et enzymkatalysatorholdigt neutralisationsmiddel til neutralisation og sønderdeling af hydrogenper-5 oxidet efter sterilisationen af en kontaktlinse.The invention relates to a contact lens cleaning kit with two treatment agents, one of which is a sterilizing hydrogen peroxide and the other an enzyme catalyst-containing neutralizing agent for neutralizing and decomposing the hydrogen peroxide after sterilizing a contact lens.

Rensesæt til bløde og hårde kontaktlinser tjener til rensning og desinfektion samt til stabilisering af de optiske egenskaber og til forbedring af brugerens bekvemmelighed. Hydr-10 ogenperoxid er som antimikrobielt stof blevet vigtigt til desinfektion og rensning af kontaktlinser. Sammenlignet med chlorhexidinsalte eller organimercuroforbindelser såsom thiomersal, som også benyttes til desinfektion af kontaktlinser, har hydrogenperoxid bedre antimikrobiel effekt, 15 især over for de forholdsvis resistente Aspergillus-arter.Cleansing kits for soft and hard contact lenses serve to cleanse and disinfect, as well as to stabilize the optical properties and to enhance user convenience. Hydr-10 ogen peroxide has become important as an antimicrobial agent for disinfecting and cleaning contact lenses. Compared to chlorhexidine salts or organo-mercury compounds such as thiomersal, which are also used to disinfect contact lenses, hydrogen peroxide has better antimicrobial effect, especially in the relatively resistant Aspergillus species.

De kendte hydrogenperoxidopløsninger, der benyttes til rensning af kontaktlinser, er 3%'s peroxidopløsninger (tysk patentskrift nr. 2.425.714). Efter behandling af kontaktlinserne med disse opløsninger, hæfter forholdsvis store 20 restmængder af hydrogenperoxidopløsning til linserne. Når de således behandlede linser anbringes på øjet, fører disse restmængder til forskellige grader af irritation af øjets slimhinde. Derfor er det efter behandling med hydrogenperoxidopløsning nødvendigt at behandle linserne med en neutra-25 liserende opløsning, ved hvis hjælp hydrogenperoxidet spaltes i vand og oxygen. Elimineringen efter sterilisation af restmængder af hydrogenperoxid ved sønderdeling ved hjælp af især tungmetalkatalysatorer kendes fra ovennævnte tyske patentskrift. Det er her nødvendigt at bruge to forskellige 30 behandlingstrin, nemlig først en sterilisering af linsen og derefter en eliminering af resthydrogenperoxidet i et vandigt system, som indeholder katalysatoren. Håndteringen af linserne og desinfektionen og rensningen er derfor forholdsvis kompliceret. Valget af passende katalysatorer, som benyttes 35 til sønderdelingen af restmængderne af hydrogenperoxid, frembyder også vanskeligheder.The known hydrogen peroxide solutions used to purify contact lenses are 3% peroxide solutions (German Patent No. 2,425,714). After treating the contact lenses with these solutions, relatively large residual amounts of hydrogen peroxide solution are adhered to the lenses. When the lenses thus treated are applied to the eye, these residual amounts lead to varying degrees of irritation of the eye's mucosa. Therefore, after treatment with hydrogen peroxide solution, it is necessary to treat the lenses with a neutralizing solution by which the hydrogen peroxide is decomposed into water and oxygen. The elimination after sterilization of residual amounts of hydrogen peroxide by decomposition by means of especially heavy metal catalysts is known from the above mentioned German patent. Here it is necessary to use two different processing steps, namely first sterilization of the lens and then elimination of the residual hydrogen peroxide in an aqueous system containing the catalyst. The handling of the lenses and the disinfection and cleansing is therefore relatively complicated. The choice of suitable catalysts used for the decomposition of the residual amounts of hydrogen peroxide also presents difficulties.

2 DK 166654 B12 DK 166654 B1

Som katalysatorer til sønderdeling af hydrogenperoxidet efter brug er det kendt at anvende enzymatiske peroxidaser, især catalase fra EP-A-82 798. Også i dette tilfælde hældes hydrogenperoxidopløsningen imidlertid bort efter desinfek-5 tionsbehandlingen, hvorpå den erstattes med en neutraliserende opløsning, som indeholder den peroxidneutraliserende katalysator, f.eks. peroxidase. Også her kræves der derfor to på hinanden følgende behandlingstrin, hvilket gør ren-seoperationen forholdsvis kompliceret.As catalysts for decomposing the hydrogen peroxide after use, it is known to use enzymatic peroxidases, in particular catalase from EP-A-82 798. However, in this case, however, the hydrogen peroxide solution is poured after the disinfection treatment and replaced with a neutralizing solution containing the peroxide neutralizing catalyst, e.g. peroxidase. Here, too, two consecutive treatment steps are required, which makes the cleaning operation relatively complicated.

10 I begge tilfælde er det umuligt at behandle en kontaktlinse under samtidig brug af hydrogenperoxid og en neutraliserende opløsning med en sønderdelingskatalysator, fordi hydrogenperoxidet i så fald sønderdeles til oxygen og vand ved hjælp 15 af den neutraliserende opløsning med sønderdelingskatalysatoren, før den har udøvet en tilstrækkelig steriliserende virkning til eliminering af alle kim på linserne, hvilket kræver 1-4 timer, især i tilfælde af bløde linser.In both cases, it is impossible to treat a contact lens while using hydrogen peroxide and a neutralizing solution with a decomposition catalyst, because then the hydrogen peroxide is decomposed to oxygen and water by the neutralizing solution with the decomposition catalyst before it has sufficient sterilizing effect to eliminate all germs on the lenses, requiring 1-4 hours, especially in the case of soft lenses.

20 Fra EP patentskrift nr. 139.994 kendes et kontaktlinseren-sesæt, hvori der anvendes hydrogenperoxid og tillige en tablet, som indeholder en forbindelse, der kan neutralisere hydrogenperoxid, og som er forsynet med et overtræk, der først opløses efter en vis tid. Som hydrogenperoxidneutra-25 liserende forbindelse anvendes forbindelser, som efter neutralisering af hydrogenperoxidet medvirker til dannelse af en pufret linseopbevaringsopløsning, og som følgelig er ionforbindelser. Det anføres endvidere i EP patentskrift nr. 139.994, at anvendelse af neutraliserende forbindelser, 30 der virker katalytisk, f.eks. peroxidase/catalase-enzym dels er kostbar, dels ikke medvirker til dannelse af en pufret linseopbevaringsopløsning. EP patentskrift nr. 139.994 repræsenterer således en fordom mod anvendelse af enzymkatalysatorer i kontaktlinserensesæt.20 EP patent specification No. 139,994 discloses a contact lens sensing kit which utilizes hydrogen peroxide and also a tablet containing a compound which can neutralize hydrogen peroxide and which is provided with a coating which dissolves only after a certain time. As the hydrogen peroxide neutralizing compound are used compounds which, after neutralizing the hydrogen peroxide, contribute to the formation of a buffered lens storage solution and are consequently ionic compounds. It is further stated in EP Patent No. 139,994 that the use of catalytic neutralizing compounds, e.g. peroxidase / catalase enzyme is partly expensive and partly does not contribute to the formation of a buffered lens storage solution. Thus, EP Patent No. 139,994 represents a prejudice against the use of enzyme catalysts in contact lens cleaning kits.

35 3 DK 166654 B135 3 DK 166654 B1

Formålet med opfindelsen er at anvise et rensesæt til kontaktlinser, som i et eneste trin holder hydrogenperoxid i aktiv form i tilstrækkelig lang tid til sterilisering af linserne, og som derefter neutraliserer restmængden af hydr-5 ogenperoxid på linserne, så at linserne derefter kan bæres uden ulemper.The object of the invention is to provide a contact lens cleaning kit which in a single step holds hydrogen peroxide in active form for a sufficient period of time to sterilize the lenses and which then neutralizes the residual amount of hydrogen and peroxide on the lenses so that the lenses can then be worn without disadvantages.

Dette formål opnås med det i kravene angivne kontaktlinse-rensesæt, og man overvinder den førnævnte fordom.This object is achieved with the contact lens cleaning kit set forth in the claims and the aforementioned prejudice is overcome.

1010

Til dette formål anviser opfindelsen et rensesæt til kontaktlinser med to behandlingsmidler: nemlig hydrogenperoxid og et neutralisationsmiddel indeholdende en enzymkatalysator. Hydrogenperoxidet er tilstrækkeligt til sterilisation af en 15 hård eller blød kontaktlinse eller begge dele. Neutralisationsmidlet er tilstrækkeligt til sønderdeling af enhver restmængde af hydrogenperoxidet på linserne til oxygen og vand, efter at hydrogenperoxidet har steriliseret linserne, så at disse kan bæres uden ulempe. Neutralisationsmidlet 20 indeholder en enzymkatalysator og et neutralisationsmiddel til sønderdeling af restmængden af hydrogenperoxid og er kombineret med et forsinkelsesmiddel. Forsinkelsesmidlet udsætter tidspunktet for frigivelsen af neutralisationsmidlet, til hydrogenperoxidet har steriliseret linserne.To this end, the invention provides a contact lens cleaning kit with two treatment agents: namely hydrogen peroxide and a neutralizing agent containing an enzyme catalyst. The hydrogen peroxide is sufficient to sterilize a hard or soft contact lens or both. The neutralizing agent is sufficient to decompose any residual amount of the hydrogen peroxide on the oxygen and water lenses after the hydrogen peroxide has sterilized the lenses so that they can be worn without disadvantage. The neutralizing agent 20 contains an enzyme catalyst and a neutralizing agent to decompose the residual amount of hydrogen peroxide and is combined with a delay agent. The delay agent delays the time of release of the neutralizing agent until the hydrogen peroxide has sterilized the lenses.

25 I overensstemmelse hermed er kontaktlinserensesættet ifølge opfindelsen ejendommeligt ved, at neutralisationsmidlet og/eller enzymkatalysatoren, som sønderdeler hydrogenperoxidet, er kombineret med et forsinkelsesmiddel, som regu-30 lerer den forsinkede frigivelse.Accordingly, the contact lens cleaning kit of the invention is peculiar in that the neutralizing agent and / or enzyme catalyst which decomposes the hydrogen peroxide is combined with a delay agent which regulates the delayed release.

Gennem opfindelsen lettes derfor resningen af kontaktlinserne, som kan være hårde eller bløde, fordi der kun kræves et enkelt trin. Linserne og neutralisationsmidlet med enzym-35 katalysatoren og forsinkelsesmidlet anbringes i en steriliserende opløsning af hydrogenperoxid. Forsinkelsesmidlet, 4 DK 166654 B1 som kommer i kontakt med hydrogenperoxidet under neddypnin-gen, frigiver da i det mindste en neutraliserende mængde af det enzymkatalysatorholdige neutralisationsmiddel, efter at hydrogenperoxidet har virket på kontaktlinserne i tilstræk-5 kelig tid til sterilisation.The invention therefore facilitates the erection of the contact lenses, which may be hard or soft because only a single step is required. The lenses and the neutralizing agent with the enzyme catalyst and the delaying agent are placed in a sterilizing solution of hydrogen peroxide. The delay agent, 4 contacting the hydrogen peroxide during the immersion, then releases at least a neutralizing amount of the enzyme catalyst-containing neutralizing agent after the hydrogen peroxide has acted on the contact lenses for a sufficient time for sterilization.

Til dette formål kan neutralisationsmidlet være overtrukket med forsinkelsesmidlet til neddypning i en vandig hydrogenpe-roxidopløsning sammen med linserne. Den forsinkede afgivelse 10 kan indstilles, især i indtil fire timer, ved hjælp af tykkelsen af det overtræk, som opløses i hydrogenperoxidopløs-ningen. Som følge af frigørelsen af det enzymkatalysatorholdige neutralisationsmiddel ved overtrækkets opløsning virker neutralisationsmidlet automatisk uden yderligere 15 indgreb fra brugerens side. Hydrogenperoxidopløsningen er sur (med en pH-værdi under 4) i den stabile tilstand til opnåelse af både sterilisation og opløsning. Enzymkatalysatoren, som befinder sig inde i overtrækket, sønderdeler derpå den steriliserende hydrogenperoxidopløsning i en be-20 handlingsbeholder, hvori linserne og neutralisationsmidlet er blevet anbragt på samme tid.For this purpose, the neutralizing agent may be coated with the delay agent for immersion in an aqueous hydrogen peroxide solution together with the lenses. The delayed release 10 can be adjusted, especially for up to four hours, by the thickness of the coating dissolved in the hydrogen peroxide solution. As a result of the release of the enzyme catalyst-containing neutralizing agent by the coating solution, the neutralizing agent operates automatically without further user intervention. The hydrogen peroxide solution is acidic (with a pH below 4) in the stable state to obtain both sterilization and solution. The enzyme catalyst located within the coating then decomposes the sterilizing hydrogen peroxide solution into a treatment vessel in which the lenses and the neutralizing agent have been placed at the same time.

Eksempler på sammensætningen af hydrogenperoxidopløsningen og af det enzymkatalysatorholdige neutralisationsmiddel er 25 angivet i tysk offentliggørelsesskrift nr. 3.410.400.Examples of the composition of the hydrogen peroxide solution and of the enzyme catalyst-containing neutralizing agent are given in German Publication No. 3,410,400.

Endvidere er følgende sammensætning egnet til neutralisationsmidlet:Furthermore, the following composition is suitable for the neutralizing agent:

0,05 vægtprocent catalasekoncentrat, 260.000 enheder/ml 30 0,05 vægtprocent hydroxypropylmethylcellulose USP XX0.05 wt% catalase concentrate, 260,000 units / ml 0.05 wt% hydroxypropyl methyl cellulose USP XX

0,05 vægtprocent NaH2P04, 2H20 DAB 8 0,25 vægtprocent Na2HP04, 2H20 0,75 vægtprocent natriumchlorid EP I0.05% by weight of NaH2PO4, 2H20 DAB 8 0.25% by weight Na2HPO4, 2H20 0.75% by weight sodium chloride EP I

35 I det følgende angives en yderligere hensigtsmæssig sammensætning af neutralisationsmidlet: 5 DK 166654 B1 3-12 mg passende pufferstof, f.eks. alkalimetalphosphat, -borat eller -citrat, glycin 40-70 mg neutral elektrolyt (f.eks. NaCl, KC1) 5-10 mg alkalimetalhydrogencarbonat 5 5-10 mg vandopløselig polymer, f.eks. polyvinylpyrrolidon 0,2-1 mg enzymkatalysator (catalase, peroxidase) pr. enkeltdosis.In the following, a further appropriate composition of the neutralizing agent is indicated: 3-12 mg of suitable buffer, e.g. alkali metal phosphate, borate or citrate, glycine 40-70 mg of neutral electrolyte (eg NaCl, KCl) 5-10 mg of alkali metal hydrogen carbonate 5-10 mg of water-soluble polymer, e.g. polyvinylpyrrolidone 0.2-1 mg enzyme catalyst (catalase, peroxidase) per single dose.

Denne mængde er tilstrækkelig til sønderdeling, til neutra-10 lisation og til regulering til en osmolaritet på 270-320 mosmol af 7 ml af en hydrogenperoxidopløsning. Disse 7 ml svarer til rumfanget af en standardkontaktlinsebeholder eller en kontaktlinsebehandlingsbeholder.This amount is sufficient for decomposition, for neutralization and for control to an osmolarity of 270-320 moles of 7 ml of a hydrogen peroxide solution. These 7 ml correspond to the volume of a standard contact lens container or contact lens treatment container.

15 Et eksempel på yderligere en særlig sammensætning af neutralisationsmidlet er som følger: 5,6 mg kaliumhydrogenphosphat 8 mg dinatriumhydrogenphosphat 52,4 mg NaCl 20 7 mg natriumhydrogencarbonat 4,8 mg polyvinylpyrrolidon K25 0,3 mg enzymkatalysatorAn example of a further particular composition of the neutralizing agent is as follows: 5.6 mg potassium hydrogen phosphate 8 mg disodium hydrogen phosphate 52.4 mg NaCl 20 7 mg sodium bicarbonate 4.8 mg polyvinylpyrrolidone K25 0.3 mg enzyme catalyst

Den ovenfor angivne sammensætning af neutralisationsmidlet 25 benyttes som kapselfyldning, idet kapslen er udformet som det forsinkelsesmiddel, som omgiver det enzymkatalysator-holdige neutralisationsmiddel. Kapslen omfatter en vandopløselig polymer, især en polyvinylalkohol.The above composition of the neutralizing agent 25 is used as capsule filling, the capsule being designed as the delay agent surrounding the enzyme catalyst-containing neutralizing agent. The capsule comprises a water-soluble polymer, especially a polyvinyl alcohol.

30 Neutralisationsmidlet kan også formes til en tablet, som forsynes med et vandopløseligt overtræk, som bevirker forsinket opløsning af tabletten. Det vandopløselige overtræk kan omfatte en polymer, som er opløselig i et surt medium, såsom en polymer af dimethylaminomethacrylat og neutrale 35 methacrylestere. Overtrækket kan også omfatte en pH-neutral opløselig polymer. Polymere, som egner sig til dette formål, DK 166654 Bl 6 er f.eks. opløselige celluloseethere såsom methylcellulose, methylhydroxypropylcellulose, methylhydroxyethylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, natriumcarb-oxymethylcellulose, celluloseacetatphthalat, hydroxypropyl-5 methylcelluloseephthalat, polymere af methacrylsyre og meth-acrylatestere, et overtræk af en vandig dispersion af en copolymer af methacrylsyre og methacrylatestere, et overtræk af en vandig dispersion af celluloseacetatphthalat, copoly-mere af methylvinylether og maleinsyreanhydrid, og polyvin-10 ylalkoholer.The neutralizing agent may also be formed into a tablet which is provided with a water-soluble coating which causes delayed dissolution of the tablet. The water-soluble coating may comprise a polymer which is soluble in an acidic medium, such as a polymer of dimethylaminomethacrylate and neutral methacrylic esters. The coating may also comprise a pH-neutral soluble polymer. Polymers suitable for this purpose, e.g. soluble cellulose ethers such as methyl cellulose, methyl hydroxypropyl cellulose, methyl hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, sodium carboxymethyl cellulose, cellulose acetate phthalate, hydroxypropyl methyl acetate acetate, aqueous dispersion of cellulose acetate phthalate, copolymer of methyl vinyl ether and maleic anhydride, and polyvinyl yl alcohols.

Passende polyalkoholer, især i en mængde på 0,2-1 mg pr. tablet, kan sættes til disse polymere til regulering af forsinkelsen. Til dette formål er især 1,2-propylenglycol, 15 polyethylenglycoler og citratestere egnede.Suitable polyalcohols, especially in an amount of 0.2-1 mg per liter. tablet, can be added to these polymers to control the delay. For this purpose, especially 1,2-propylene glycol, 15 polyethylene glycols and citrate esters are suitable.

Overtrækket kan fremstilles ud fra den vandopløselige polymer under anvendelse af velkendte fremgangsmåder, f.eks. ved påsprøjtning af en film i en overtræksbeholder, ved fluidi-20 sering (Wurster-metode) eller i lukkede systemer. Den foretrukne mængde polymer til overtrækning af en tablet er 2,0- 5,0 mg.The coating may be prepared from the water-soluble polymer using well known methods, e.g. by spraying a film into a coating container, by fluidization (Wurster method) or in closed systems. The preferred amount of polymer for coating a tablet is 2.0 to 5.0 mg.

Nedenfor er der givet et eksempel på en tabletsammensætning, 25 som udgør det enzymkatalysatorholdige neutralisationsmiddel: 11,2 mg dinatriumhydrogenphosphat 55,8 mg NaCl 4,8 g polyvinylpyrrolidon K25 0,2 mg enzymkatalysator (catalase, peroxidase) 30Below is an example of a tablet composition 25 which is the enzyme catalyst-containing neutralizing agent: 11.2 mg disodium hydrogen phosphate 55.8 mg NaCl 4.8 g polyvinylpyrrolidone K25 0.2 mg enzyme catalyst (catalase, peroxidase) 30

Nedenfor er der anført et eksempel på en syreopløselig polymer, der egner sig som overtræk: 1,9 mg methacrylatester 0,4 mg hydroxypropylmethylcellulose 35 0,2 mg polyethylenglycol (1000) 7 DK 166654 B1 oBelow is an example of an acid-soluble polymer suitable as a coating: 1.9 mg methacrylate ester 0.4 mg hydroxypropylmethylcellulose 35 0.2 mg polyethylene glycol (1000) 7 DK 166654 B1 o

Nedenfor er der anført et eksempel på en overtræksfilm af en polymer, som er opløselig i neutralt miljø: 2.2 mg hydroxypropylmethylcellulosephthalat 5 0,3 mg polyethylenglycol (1000)Below is an example of a coating film of a polymer which is soluble in neutral environment: 2.2 mg hydroxypropylmethylcellulose phthalate 5 0.3 mg polyethylene glycol (1000)

Det er også muligt at forsegle et enzymkatalysatorholdigt neutralisationsmiddel, som er formet til en tablet, med en vandopløselig film af f.eks. polyvinylalkohol, som virker 10 som forsinkelsesmiddel. Blødgørere i form af polyvalente alkoholer og vand sættes i en mængde på 3,5%-5% til polyvinylalkohol filmen, hvorved der opnås en forsinket opløsning af filmen. Filmen kan have en tykkelse på 30-150 μπι. Gasper-meabiliteten (DIN 53 380) er 0,9-1,4 ml/m2/<Vkar· Filmene 15 kan svejses ved temperaturer på 140-190°C ved et kontakttryk på 4-5 bar.It is also possible to seal an enzyme catalyst-containing neutralizing agent formed into a tablet with a water-soluble film of e.g. polyvinyl alcohol which acts as a delay agent. Plasticizers in the form of polyhydric alcohols and water are added in an amount of 3.5% -5% to the polyvinyl alcohol film, whereby a delayed solution of the film is obtained. The film can have a thickness of 30-150 μπι. The gas permeability (DIN 53,380) is 0.9-1.4 ml / m2 / <Vkar · The films 15 can be welded at temperatures of 140-190 ° C at a contact pressure of 4-5 bar.

Det enzymkatalysatorholdige neutralisationsmiddel i form af en tablet kan også overtrækkes med en uopløselig, men dog 20 semipermeabel membran. Denne membran kan også påføres ved anvendelse af kendte overtræksmetoder såsom ved påsprøjtning, ved fluidisering eller i lukkede systemer i en mængde på 3-10 mg pr. tablet. Den semipermeable membran kan f.eks. dannes ud fra en organisk opløsning af ethylcellulose, en vandig 25 dispersion af ethylcellulose, en copolymer af acrylat/meth-acrylat-estere med trimethylammoniummethacrylat, en vandig dispersion af blandede methylmethacrylater og ethylmethacry 1 -ater. Til regulering af diffusionshastigheden kan der tilsættes passende blødgørere, især i en mængde på 1,5-5,0 mg 30 pr. tablet. Som blødgørere kan anvendes 1,2-propylenglycol, polyethylenglycoler og citratestere. Et eksempel på sammensætningen af en semipermeabel membran er som følger: 3,8 mg ethylcellulose N22 1.2 mg polyethylenglycol (6.000) 35The enzyme catalyst-containing neutralizing agent in the form of a tablet can also be coated with an insoluble, but 20 semipermeable membrane. This membrane can also be applied using known coating methods such as by spraying, by fluidization or in closed systems in an amount of 3-10 mg / ml. tablet. The semipermeable membrane can e.g. is formed from an organic solution of ethyl cellulose, an aqueous dispersion of ethyl cellulose, a copolymer of acrylate / methacrylate esters with trimethylammonium methacrylate, an aqueous dispersion of mixed methyl methacrylates and ethyl methacrylic 1-aates. To adjust the rate of diffusion, suitable plasticizers may be added, especially in an amount of 1.5-5.0 mg / ml. tablet. 1,2-propylene glycol, polyethylene glycols and citrate esters can be used as plasticizers. An example of the composition of a semi-permeable membrane is as follows: 3.8 mg ethylcellulose N22 1.2 mg polyethylene glycol (6,000) 35

Et yderligere eksempel på et forsinkelsesmiddel, ved hvis 8 DK 166654 B1 ΰ hjælp der kan opnås en forsinket afgivelse af enzymkataly-satoren, der sønderdeler hydrogenperoxidet, og af neutralisationsmidlet, er en kvældbar, men dog tungtopløselig eller uopløselig matrix, især i tabletform, hvori det enzymkata-5 lysatorholdige neutralisationsmiddel er fordelt. Det enzym-katalysatorholdige neutralisationsmiddel, der kan have en af ovenstående sammensætninger, indkorporeres i den omtalte matrix, som kan omfatte naturlig eller delvis syntetisk polymere. Den især tabletformede matrix kan fremstilles ved 10 konventionelle processer, f.eks. ved granulering og støbning af udgangsmaterialerne. Det er også muligt at forarbejde blandingen af udgangsmaterialer direkte til tabletter uden forudgående granulering. Polymere, som egner sig til dannelse af matrixen, er opløselige celluloseethere såsom de oven-15 nævnte, alkalimetalsalte af alginsyre, methacrylsyrederiva-ter, især acrylat/methacrylat-estere, acryl syrederivater, dextraner (molekylvægt 1.000-75.000) og polyvinylalkoholer. Nedenfor er der anført et eksempel på en matrix, hvori det enzymkatalysatorholdige neutralisationsmiddel er inkorpore-20 ret: 0,3 mg enzymkatalysator (catalase, peroxidase) 10,2 mg dinatriumhydrogenphosphat 55,8 mg NaCl 4,7 mg polyvinylpyrrolidon K25 25 15 mg hydroxypropylmethylcelluloseA further example of a delay agent by which a delayed release of the enzyme catalyst which decomposes the hydrogen peroxide and of the neutralizing agent can be obtained is a swellable, yet highly soluble or insoluble matrix, especially in tablet form, wherein the enzyme catalyst-containing neutralizing agent is distributed. The enzyme catalyst-containing neutralizing agent, which may have any of the above compositions, is incorporated into the aforementioned matrix which may comprise natural or partially synthetic polymer. The particularly tablet-shaped matrix can be prepared by 10 conventional processes, e.g. by granulating and casting the starting materials. It is also possible to process the mixture of starting materials directly into tablets without prior granulation. Polymers suitable for forming the matrix are soluble cellulose ethers such as the aforementioned alkali metal salts of alginic acid, methacrylic acid derivatives, especially acrylate / methacrylate esters, acrylic acid derivatives, dextrans (molecular weight 1,000-75,000) and polyvinyl alcohols. Below is an example of a matrix incorporating the enzyme catalyst-containing neutralizing agent: 0.3 mg of enzyme catalyst (catalase, peroxidase) 10.2 mg of disodium hydrogen phosphate 55.8 mg of NaCl 4.7 mg of polyvinylpyrrolidone K25 25 mg of hydroxypropyl methylcellulose

Der støbes tabletter med en vægt på f.eks. 86 mg og en diameter på 6 mm.Tablets with a weight of e.g. 86 mg and a diameter of 6 mm.

30 Det er også muligt at inkorporere enzymkatalysatoren og neutralisationsmidlet i en høj koncentreret vandig polymeropløsning, hvoraf der ved støbning og tørring kan fremstilles folier med en tykkelse på 1,0-3,0 mm. Ved opskæring af folien til den ønskede størrelse kan der fremstilles passende en-35 hedsdoser med forudberegnede overfladedimensioner. De vandopløselige polymere virker som forsinkelsesmidler, hvorved 9 DK 166654 B1 man opnår en forsinket afgivelse af enzymkatalysator og neutralisationsmiddel. Passende polymere er vandopløselige celluloseethere som ovennævnte, alkalimetalalginater, dex-traner og polyvinylalkoholer.It is also possible to incorporate the enzyme catalyst and the neutralizing agent into a highly concentrated aqueous polymer solution, from which foils having a thickness of 1.0-3.0 mm can be prepared. By cutting the film to the desired size, suitable unit doses with predetermined surface dimensions can be prepared. The water-soluble polymers act as delay agents, thereby providing a delayed release of enzyme catalyst and neutralizing agent. Suitable polymers are water-soluble cellulose ethers such as the above, alkali metal alginates, dextranes and polyvinyl alcohols.

55

Det er kendt ved indgiften af lægemidler at benytte terapeutiske systemer i form af tabletter, semipermeable membraner og matricer, som anbringes i bestemte målområder i et biosystem til opnåelse af en konstant afgivelse af lægemidlet 10 i løbet af et længere tidsrum. I modsætning til dette opnår man gennem den foreligende opfindelse, at den hydrogenper-oxidsønderdelende enzymkatalysator sammen med det steriliserende hydrogenperoxid kan benyttes på samme tid til behandling af kontaktlinser uden skadelig virkning fra enzym-15 katalysatoren på hydrogenperoxidets ønskede sterilisationsvirkning i en periode på f.eks. 4 timer. Enzymkatalysatorens sønderdelende virkning på hydrogenperoxidet starter først ved slutningen af den ønskede behandlingstid.It is known in the administration of drugs to use therapeutic systems in the form of tablets, semipermeable membranes and matrices placed in specific target areas of a biosystem to obtain a constant release of the drug 10 over a prolonged period of time. In contrast, the present invention provides that the hydrogen peroxide decomposing enzyme catalyst together with the sterilizing hydrogen peroxide can be used at the same time to treat contact lenses without detrimental effect from the enzyme catalyst on the desired sterilization effect of the hydrogen peroxide for a period of e.g. . 4 hours. The disintegrating effect of the enzyme catalyst on the hydrogen peroxide starts only at the end of the desired treatment time.

20 En forsinket afgivelse af enzymkatalysatoren kan også opnås ved immobilisering af enzymkatalysatoren på partikelformede bærestoffer, især acrylharpikspartikler, f.eks. ved binding ved hjælp af reaktionsdygtige oxirangrupper. Bærestofferne sammen med enzymkatalysatoren, som er immobiliseret derpå, 25 anbringes i passende mængde på f.eks. bunden eller låget af en kontaktlinsebehandlingsbeholder med gevind og adskilles fra behandlingsopløsningen, som indeholder de pH-neutrali-serende materialer og de neutrale salte sammen med hydrogenperoxidet, ved hjælp af permeable indifferente netformede 30 sier. I denne udformning er enzymkatalysatoren anbragt i den ene del af behandlingsbeholderen uden sammenblanding med behandlingsopløsningen. På denne måde undgås risikoen for, at enzymkatalysatormaterialet akkumuleres i de bløde linser under behandling af linserne. F.eks. kan en mængde 35 bærestof med immobiliseret enzymkatalysator til 30 dages brug. anbringes i beholderdelen.A delayed release of the enzyme catalyst can also be achieved by immobilizing the enzyme catalyst on particulate carriers, especially acrylic resin particles, e.g. by binding by reactive oxirane groups. The carriers, together with the enzyme catalyst immobilized thereon, are applied in an appropriate amount, e.g. the bottom or lid of a threaded contact lens treatment container and separated from the treatment solution containing the pH neutralizing materials and neutral salts together with the hydrogen peroxide by permeable inert mesh webs. In this embodiment, the enzyme catalyst is placed in one portion of the treatment vessel without mixing with the treatment solution. In this way, the risk of the enzyme catalyst material being accumulated in the soft lenses during treatment of the lenses is avoided. Eg. can use an amount of 35 carrier with immobilized enzyme catalyst for 30 days of use. placed in the container part.

DK 166654 B1 10DK 166654 B1 10

Behandlingsopløsningen, hvori frigivelsen af det enzymkata-lysatorholdige neutraliseringsmiddel finder sted, kan have en pH-værdi på 7-7,5, især 7,3 og en osmolaritet på ca. 300 5 mosmol.The treatment solution in which the release of the enzyme catalyst-containing neutralizing agent takes place may have a pH of 7-7.5, especially 7.3 and an osmolarity of approx. 300 5 mosmol.

Et farveskift, især ved brug af en farveindikator (pH/redox-indikator), som skifter farve ved en pH-værdi på 7,0-7,5 og især ved 7,3, fortæller brugeren, at hydrogenperoxidet, som 10 er brugt til sterilisationsbehandlingen, er blevet sønderdelt. Til dette formål egner sig navnlig højmolekylære farvestoffer, som ikke trænger ind i linsematerialet.A color change, especially when using a color indicator (pH / redox indicator) which changes color at a pH of 7.0-7.5 and especially at 7.3, tells the user that the hydrogen peroxide used is 10 for the sterilization treatment, has been disintegrated. For this purpose, in particular, high molecular colors which do not penetrate the lens material are suitable.

For at enzymkatalysatoren kun skal udøve sin virkning efter 15 desinfektion- og sterilisationsbehandlingen af linserne, kan dette enzymkatalysatoradditiv, som tillige med hjælpematerialerne er til stede i neutralisationsmidlet, og som tjener til neutralisation af hydrogenperoxid, forsynes med et overtræk, som sikrer at enzymkatalysatoren til sønderde-20 ling af hydrogenperoxidet kun frigøres efter den fornødne behandlingstid på indtil 4 timer. Der er mange muligheder til opnåelse af dette.In order for the enzyme catalyst to exert its effect only after the disinfection and sterilization treatment of the lenses, this enzyme catalyst additive, as well as the auxiliary materials present in the neutralizing agent, which serves to neutralize hydrogen peroxide, can be provided with a coating which ensures that the enzyme catalyst is used. -20 ling of the hydrogen peroxide is released only after the required treatment time of up to 4 hours. There are many ways to achieve this.

Overtrækket på enzymkatalysatoren og hjælpematerialerne kan 25 have form af en kapsel, som er vandopløselig ved den pH-værdi, hvor hydrogenperoxidopløsningen er stabil, dvs. ved en pH-værdi ved 4-5, og som ikke flokkuleres eller udfældes i neutral opløsning, dvs. ved en pH-værdi på 7,3.The coating on the enzyme catalyst and the auxiliary materials may take the form of a capsule which is water soluble at the pH at which the hydrogen peroxide solution is stable, i.e. at a pH value of 4-5 and which is not flocculated or precipitated in neutral solution, i.e. at a pH of 7.3.

30 Det er endvidere en fordel, at kapslen har en eller to eller eventuelt flere laserperforeringer, gennem hvilke hjælpematerialerne frigøres ved kontakt med hydrogenperoxidopløsningen, idet kapslen opløses helt, når en pH-værdi på ca. 7 er nået, med henblik på frigivelse af enzymkatalysatoren på 35 dette tidspunkt.It is further advantageous that the capsule has one or two or optionally several laser perforations through which the auxiliary materials are released upon contact with the hydrogen peroxide solution, the capsule dissolving completely when a pH of approx. 7 is reached for release of the enzyme catalyst at this time.

11 DK 166654 B111 DK 166654 B1

Enzymkatalysatoren kan også være til stede som enzymkorn eller -granulat (prill), som sammen med hjælpematerialerne fyldes i kapslen, som har de førnævnte opløselighedsegenska-ber.The enzyme catalyst may also be present as enzyme granules or granules (prill) which, together with the auxiliary materials, are filled into the capsule having the aforementioned solubility properties.

55

Det enzymkatalysatorholdige neutralisationsmiddel kan også formes til en overtrukket tablet, fra hvilken - med den forsinkede opløsning af overtrækket - først og fremmest hjælpematerialerne frigøres til ændring af pH-værdien af 10 hydrogenperoxidopløsningen, hvorpå enzymkatalysatoren frigøres ved en pH-værdi på ca. 7.The enzyme catalyst-containing neutralizing agent can also be formed into a coated tablet, from which - with the delayed solution of the coating - first of all, the auxiliary materials are released to change the pH of the hydrogen peroxide solution, whereupon the enzyme catalyst is released at a pH of approx. 7th

Egnet til det enzymkatalysatorholdige neutralisationsmiddel er endvidere en tolagstablet, hvor det ene lag, som indehol-15 der opløselige salte, tjener til at neutralisere hydrogenperoxidopløsningen, medens det andet lag indeholder enzymkatalysatoren, idet det er muligt at frigøre enten hjælpematerialerne eller enzymkatalysatoren først.Furthermore, suitable for the enzyme catalyst-containing neutralizing agent is a two-layered tablet, where one layer containing soluble salts serves to neutralize the hydrogen peroxide solution, while the other layer contains the enzyme catalyst, it being possible to release either the auxiliary materials or the enzyme catalyst first.

20 Neutralisationsmidlet kan også være til stede som en basisk gel i et overtræk, som er opløseligt ved en pH-værdi på 7. Enzymkatalysatoren kan også være til stede som en viskos opløsning af et overtræk, som omgiver hjælpematerialerne.The neutralizing agent may also be present as a basic gel in a coating which is soluble at a pH of 7. The enzyme catalyst may also be present as a viscous solution of a coating surrounding the auxiliary materials.

25 Endvidere kan neutralisationsmidlet have en semipermeabel membran som overtræk, gennem hvilket det vand, som skal opløse hjælpestofferne, trænger ind i det indre, og hvorfra de opløste salte når ydersiden på grund af det osmotiske tryk. Til dette formål kan den semipermeable membran have 30 en perforation, eller den kan ødelægges af det osmotiske tryk, hvorved hjælpematerialerne og enzymkatalysatoren frigøres. Enzymkatalysatoren kan være til stede som et indhyllet enzymprodukt.Furthermore, the neutralizing agent may have a semi-permeable membrane as a coating through which the water which is to dissolve the excipients enters the interior and from which the dissolved salts reach the outside due to the osmotic pressure. For this purpose, the semipermeable membrane may have a perforation, or it may be destroyed by the osmotic pressure, thereby releasing the auxiliary materials and enzyme catalyst. The enzyme catalyst may be present as a shrouded enzyme product.

35 Desuden er et tolagssystem med en opløselig og en semipermeabel membran egnet til forsinket frigivelse af hjælpema- 12 DK 166654 B1 terialerne og enzymkatalysatoren. Et uopløseligt membransystem kan udskiftes ved fornyet brug.In addition, a two-layer system with a soluble and a semi-permeable membrane is suitable for delayed release of the auxiliary materials and enzyme catalyst. An insoluble membrane system can be replaced by reuse.

Et passende tolagssystem kan konstrueres på en sådan måde, 5 at enzymkatalysatoren er omgivet af den semipermeable membran, på hvis yderside hjælpematerialerne findes. Et overtræk, som er opløseligt ved pH-værdien (mindre end 4) i den stabile hydrogenperoxidopløsning, omgiver endvidere hjælpematerialerne og den semipermeable membran, som omslutter 10 enzymkatalysatoren.An appropriate two-layer system can be constructed in such a way that the enzyme catalyst is surrounded by the semipermeable membrane on whose outer auxiliary materials are located. Furthermore, a coating which is soluble at the pH (less than 4) in the stable hydrogen peroxide solution surrounds the auxiliary materials and the semipermeable membrane enclosing the enzyme catalyst.

Sønderdelingen af hydrogenperoxidet kan påvises ved hjælp af en farveindikator. I denne forbindelse er det et spørgsmål om tilsætning af en pH/redoxindikator, som ikke trænger ind 15 i de bløde hydrofile kontaktlinser, og som er fysiologisk sikker. Farveindikatoren kan også være indrettet på en sådan måde, at den har en farve ved en pH-værdi på 7 i nærværelse af hydrogenperoxid og er farveløs ved en pH-værdi på 7 i fravær af hydrogenperoxid.The decomposition of the hydrogen peroxide can be detected by a color indicator. In this connection, it is a matter of adding a pH / redox indicator which does not penetrate into the soft hydrophilic contact lenses and is physiologically safe. The color indicator may also be arranged such that it has a color at a pH of 7 in the presence of hydrogen peroxide and is colorless at a pH of 7 in the absence of hydrogen peroxide.

2020

Den beholder, hvori kontaktlinsebehandlingen foretages, kan have ventilationsorganer i form af f.eks. en Bunsen-ventil, gennem hvilken det oxygen, som frigøres under neutralisationen og sønderdelingen af hydrogenperoxidet, kan undvige.The container in which the contact lens treatment is performed may have ventilation means in the form of e.g. a Bunsen valve through which the oxygen released during the neutralization and decomposition of the hydrogen peroxide can be avoided.

2525

Opfindelsen skal forklares nærmere i det følgende med henvisning til tegningen, hvor fig. 1-5 viser forskellige eksempler på systemer, som indeholder hydrogenperoxid og sønderdelingsenzymkata-30 lysator, fig. 6 viser tidsforløbet for behandlingen af en kontaktlinse med et eksempel på brugen af kontaktlinserensesættet, fig. 7 viser en behandlingsbeholder set fra siden, og fig. 8 viser et planbillede af en beholderdel, som kan skrues 35 ind i behandlingsbeholderen, og som indeholder par tikelformede bærestoffer, hvortil en hydrogenperoxid- 13 DK 166654 B1 sønderdelende enzymkatalysator er bundet.The invention will be explained in more detail below with reference to the drawing, in which 1-5 show various examples of systems containing hydrogen peroxide and decomposition enzyme catalyst; Figure 6 shows the time course of processing a contact lens with an example of the use of the contact lens cleaning kit; 7 is a side view of a treatment container; and FIG. Figure 8 shows a plan view of a container portion that can be screwed into the treatment container and containing particulate carriers to which a hydrogen peroxide decomposing enzyme catalyst is attached.

I det i fig. 1 viste eksempel er hjælpematerialer 1 og en hydrogenperoxidspaltende enzymkatalysator 2, f.eks. i form 5 af catalase, tilfældigt fordelt i et ydre hylster eller overtræk 3. Dette ydre overtræk 3 kan være vandopløseligt eller semipermeabelt, efter at det har været udsat for indvirkning i et vist tidsrum af hydrogenperoxidet, som har en steriliserende virkning på de kontaktlinser, som skal be-10 handles. Tykkelsen af overtrækket regulerer det tidsrum på indtil 4 timer, hvori hydrogenperoxidet virker på linserne, før der er frigivet en tilstrækkelig mængde catalase og hjælpematerialer ved opløsning af overtrækket 3 eller i kraft af semipermeabiliteten af dette overtræk, så at det 15 steriliserende hydrogenperoxid neutraliseres og elimineres ved enzymkatalytisk sønderdeling. I dette eksempel kan hjælpematerialerne og enzymkatalysatoren frigøres på samme tid.In the embodiment of FIG. 1, auxiliary materials 1 and a hydrogen peroxide cleaving enzyme catalyst 2, e.g. in the form 5 of catalase, randomly distributed in an outer casing or coating 3. This outer coating 3 may be water-soluble or semi-permeable after being subjected to action for a certain period of time by the hydrogen peroxide having a sterilizing effect on the contact lenses. to be treated. The thickness of the coating regulates the period of up to 4 hours during which the hydrogen peroxide acts on the lenses, before a sufficient amount of catalase and auxiliary materials are released by dissolving the coating 3 or by virtue of the semi-permeability of this coating to neutralize and eliminate the sterilizing hydrogen peroxide. by enzyme catalytic decomposition. In this example, the auxiliary materials and enzyme catalyst can be released at the same time.

I det i fig. 2 viste eksempel frigøres hjælpematerialerne 1 20 først, hvorved den steriliserende hydrogenperoxidopløsning neutraliseres. Derefter skal den hydrogenperoxidødelæggende enzymkatalysator 2, f.eks. i form af catalase, virke. Til dette formål forefindes et ydre hylster eller overtræk 3, som efter indvirkningen af hydrogenperoxidet i et vist tids-25 rum er opløseligt, eller som er tilstrækkeligt semipermeabelt, og som omgiver hjælpematerialerne 1. Hjælpematerialeme 1 omgiver enzymkatalysatoren 2, som atter er omgivet af et indre hylster eller overtræk 4, som også kan være opløseligt eller semipermeabelt.In the embodiment of FIG. 2, the auxiliary materials 1 20 are first released, thereby neutralizing the sterilizing hydrogen peroxide solution. Then the hydrogen peroxide-destroying enzyme catalyst 2, e.g. in the form of catalase, works. For this purpose, there is provided an outer casing or coating 3 which, after the action of the hydrogen peroxide, is soluble or sufficiently semipermeable and surrounds the auxiliary materials 1. The auxiliary materials 1 surround the enzyme catalyst 2, which is again surrounded by a inner sleeve or coating 4 which may also be soluble or semi-permeable.

30 I det i fig. 3 viste eksempel ligger enzymkatalysatoren 2 og hjælpematerialerne 1 ved siden af hinanden og er omgivet af et fælles ydre hylster eller overtræk, som er vandopløseligt eller semipermeabelt. I dette tilfælde kan hjælpematerialeme 35 1 og enzymkatalysatoren 2 være adskilt ved hjælp af en skil levæg 5.30 In the embodiment of FIG. 3, the enzyme catalyst 2 and the auxiliary materials 1 are adjacent to each other and are surrounded by a common outer casing or coating which is water-soluble or semi-permeable. In this case, the auxiliary materials 35 1 and the enzyme catalyst 2 can be separated by a separate living egg 5.

14 DK 166654 B1 1 det i fig. 4 viste eksempel frigøres enzymkatalysatoren 2, som kan være til stede i form af en viskos opløsning, først, hvorefter hjælpematerialerne 1 frigøres. Enzymkata- 5 lysatoren 2 er her omgivet af et ydre hylster eller overtræk 3, og hjælpematerialerne 1 er omgivet af et indre hylster eller overtræk 4. I denne udformning ligger hjælpematerialerne 1 inderst og er omgivet af enzymkatalysatoren 2.14 DK 166654 B1 shown in FIG. 4, the enzyme catalyst 2, which may be present in the form of a viscous solution, is first released, after which the auxiliary materials 1 are released. In this embodiment, the enzyme catalyst 2 is surrounded by an outer casing or coating 3, and the auxiliary materials 1 are surrounded by an inner casing or coating 4. In this embodiment, the auxiliary materials 1 are innermost and surrounded by the enzyme catalyst 2.

10 I det i fig. 5 viste eksempel foreligger enzymkatalysatoren 2 i form af små katalysatorkorn eller -prill, og hjælpematerialerne 1 er tilfældigt fordelt i det ydre hylster eller overtræk 3, som kan være opløseligt eller semipermeabelt.10 In the embodiment of FIG. 5, the enzyme catalyst 2 is in the form of small catalyst grains or prills, and the auxiliary materials 1 are randomly distributed in the outer casing or coating 3 which may be soluble or semi-permeable.

15 Fig. 6 er en grafisk fremstilling af tidsforløbet af behandlingen af kontaktlinserne med hydrogenperoxid og den efterfølgende ødelæggelse af hydrogenperoxidet, når det har virket i et ønsket tidsrum t]_. Det tidsrum, hvori hydrogenperoxidet virker, kan f.eks. fastlægges ved hjælp af tykkelsen af 20 overtrækket eller ved passende valg af overtræksmaterialet. Hydrogenperoxidindh'oldet er vist som ordinat, og det ses, at begyndelseskoncentrationen af hydrogenperoxid forbliver praktisk taget konstant indtil slutningen af tidsrummet for indvirkning t^. Efter frigørelse af hjælpemidlerne og/eller 25 enzymkatalysatoren falder hydrogenperoxidindholdet i behandlingsbeholderen hurtigt.FIG. 6 is a graphical representation of the time course of the treatment of the contact lenses with hydrogen peroxide and the subsequent destruction of the hydrogen peroxide when it has worked for a desired period of time. For example, the period of time during which the hydrogen peroxide works is determined by the thickness of the coating or by appropriate selection of the coating material. The hydrogen peroxide content is shown as ordinate, and it is seen that the initial concentration of hydrogen peroxide remains practically constant until the end of the period of action t ^. Upon release of the adjuvants and / or the enzyme catalyst, the hydrogen peroxide content of the treatment vessel drops rapidly.

Fig. 7 og 8 viser skematisk et eksempel på brugen af en behandlingsbeholder 1, hvori der i en forsænkning 4 i en 30 bunddel 2 er anbragt partikel formede bærestoffer 3, på hvilke en hydrogenperoxidnedbrydende enzymkatalysator er immobili-seret. Bunddelen 2 kan f.eks. være fastgjort ved hjælp af et gevind til behandlingsbeholderdelen 2 f.eks. som beskrevet i tysk offentliggørelsesskrift nr. 3.410.400. Bærestofferne 35 3, som er overtrukket med enzymkatalysatoren, er adskilt fra det indre 7 af beholderen ved hjælp af et indifferent 15 DK 166654 B1 sivæv 6, som er impermeabelt for den behandlingsopløsning, som findes i det indre 7 af beholderen. Farven af låget 8, som også er påskruet, og hvortil beholderne 9 for kontaktlinserne, som skal behandles, er fastgjort, som vist i tysk 5 offentliggørelsesskrift nr. 3.410.400, kan have en anden farve end farven af den påskruede bunddel 2, så at forveksling undgås.FIG. 7 and 8 show schematically an example of the use of a treatment container 1 in which a recess 4 in a bottom part 2 has particulate carriers 3 on which a hydrogen peroxide degrading enzyme catalyst is immobilized. The bottom part 2 can e.g. be secured by a thread to the treatment container part 2 e.g. as described in German Publication No. 3,410,400. The carriers 35 3 coated with the enzyme catalyst are separated from the inner 7 of the container by an inert tissue 6 which is impermeable to the treatment solution contained within the inner 7 of the container. The color of the lid 8, which is also screwed on, to which the containers 9 of the contact lenses to be treated are attached, as shown in German 5 Publication No. 3,410,400, may have a different color from the color of the screwed-on bottom part 2, so that confusion is avoided.

Claims (41)

1. Kontaktlinserensesæt med to behandlingsmidler, hvoraf det ene er et steriliserende hydrogenperoxid, og det andet 5 er et enzymkatalysatorholdigt neutralisationsmiddel til neutralisation og sønderdeling af hydrogenperoxidet efter sterilisationen af en kontaktlinse, kendetegnet ved, at neutralisationsmidlet og/eller enzymkatalysatoren, som sønderdeler hydrogenperoxidet, er kombineret med et 10 forsinkelsesmiddel, som regulerer den forsinkede frigivelse.1. Contact lens cleaning kit with two treating agents, one of which is a sterilizing hydrogen peroxide and the other 5 is an enzyme catalyst-containing neutralizing agent for neutralizing and decomposing the hydrogen peroxide after sterilizing a contact lens, characterized in that the neutralizing agent and / or the enzyme catalyst is the combined with a delay agent which regulates the delayed release. 2. Kontaktlinserensesæt ifølge krav 1, kendetegnet ved, at det enzymkatalysatorholdige neutralisationsmiddel er omsluttet af et overtræk, som i kontakt med hydr- 15 ogenperoxidopløsningen frigør det enzymkatalysatorholdige neutralisationsmiddel efter hydrogenperoxidopløsningens indvirkning i et bestemt tidsrum på kontaktlinsen, som skal behandles.Contact lens cleaning kit according to claim 1, characterized in that the enzyme catalyst-containing neutralizing agent is enclosed by a coating which, in contact with the hydrogen peroxide solution, releases the enzyme catalyst-containing neutralizing agent after the effect of the hydrogen peroxide solution for a specified period of time on the contact lens to be treated. 3. Kontaktlinserensesæt ifølge krav 1 eller 2, ken detegnet ved, at neutralisationsmidlet foruden enzymkatalysatoren til sønderdeling af hydrogenperoxidet indeholder hjælpematerialer, som neutraliserer den sure hydr-ogenperoxidopløsning. 25Contact lens cleaning kit according to claim 1 or 2, characterized in that the neutralizing agent, in addition to the enzyme catalyst for decomposition of the hydrogen peroxide, contains auxiliary materials which neutralize the acidic hydrogen and peroxide solution. 25 4. Kontaktlinserensesæt ifølge et af kravene 1-3, kendetegnet ved, at enzymkatalysatoren til sønderdeling af hydrogenperoxidet frigøres før eller efter hjælpematerialerne til neutralisationen af hydrogenperoxidopløsningen. 30Contact lens cleaning kit according to one of claims 1-3, characterized in that the enzyme catalyst for decomposition of the hydrogen peroxide is released before or after the auxiliary materials for the neutralization of the hydrogen peroxide solution. 30 5. Kontaktlinserensesæt ifølge et af kravene 1-4, kendetegnet ved, at forsinkelsesmidlet foreligger som et vandopløseligt overtræk for det enzymkatalysatorholdige neutralisationsmiddel og består af en polymer, som er vand- 35 opløselig i surt eller neutralt medium. DK 166654 B1Contact lens cleaning kit according to one of claims 1-4, characterized in that the delay agent is present as a water-soluble coating for the enzyme catalyst-containing neutralizing agent and consists of a polymer which is water-soluble in acidic or neutral medium. DK 166654 B1 6. Kontaktlinserensesæt ifølge krav 5, kendetegnet ved, at polymeren, som er opløselig i surt medium, er en polymer af dimethylaminomethacrylat og neutrale meth-acrylsyreestere. 5Contact lens cleaning kit according to claim 5, characterized in that the polymer, which is soluble in acidic medium, is a polymer of dimethylaminomethacrylate and neutral methacrylic acid esters. 5 7. Kontaktlinserensesæt ifølge krav 5, kendetegnet ved, at polymeren, som er opløselig i neutralt medium, er en forbindelse valgt blandt opløselige celluloseethere, celluloseacetatphthalat, hydroxypropylmethylcellulosephthal- 10 at, en polymer af methacrylsyre og methacrylsyreestere, en copolymer af methacrylsyre og methacrylsyreestere, en copolymer af methylvinylether og maleinsyreanhydrod, og polyvin-ylalkoholer.Contact lens cleaning kit according to claim 5, characterized in that the polymer, which is soluble in neutral medium, is a compound selected from soluble cellulose ethers, cellulose acetate phthalate, hydroxypropylmethylcellulose phthalate, a polymer of methacrylic acid and methacrylic acid acetate, a copolymer and a copolymer copolymer of methyl vinyl ether and maleic anhydride, and polyvinyl yl alcohols. 8. Kontaktlinserensesæt ifølge krav 7, kendeteg net ved, at de opløselige celluloseethere er methylcel-lulose, methylhydroxypropylcellulose, methylhydroxyethylcel-lulose, hydroxypropylcellulose, hydroxyethylcellulose og natriumcarboxymethylcellulose. 20Contact lens cleaning kit according to claim 7, characterized in that the soluble cellulose ethers are methyl cellulose, methyl hydroxypropyl cellulose, methyl hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose and sodium carboxymethyl cellulose. 20 9. Kontaktlinserensesæt ifølge et af kravene 5-8, ken detegnet ved, at polyalkoholer er sat til den vandopløselige polymer til regulering af forsinkelsestiden.Contact lens cleaning kit according to one of claims 5-8, characterized in that polyalcohols are added to the water-soluble polymer for controlling the delay time. 10. Kontaktlinserensesæt ifølge krav 9, kendeteg net ved, at polyalkoholerne er 1,2-propylenglycol, poly-ethylenglycol og citronsyre.Contact lens cleaning kit according to claim 9, characterized in that the polyalcohols are 1,2-propylene glycol, polyethylene glycol and citric acid. 11. Kontaktlinserensesæt ifølge et af kravene 1-10, 30 kendetegnet ved, at overtrækket har form af en vandopløselig film.Contact lens cleaning kit according to one of claims 1-10, 30, characterized in that the coating takes the form of a water-soluble film. 12. Kontaktlinserensesæt ifølge krav 5 eller 11, kendetegnet ved, at overtrækket består af polyvinylal- 35 kohol. DK 166654 B1Contact lens cleaning kit according to claim 5 or 11, characterized in that the coating consists of polyvinyl alcohol. DK 166654 B1 13. Kontaktlinserensesæt ifølge krav 11 eller 12, kendetegnet ved, at polyvinylalkoholfilmen indeholder blødgørere af polyvalente alkoholer og vand i en mængde på 3,5-5%. 5Contact lens cleaning kit according to claim 11 or 12, characterized in that the polyvinyl alcohol film contains plasticizers of polyhydric alcohols and water in an amount of 3.5-5%. 5 14. Kontaktlinserensesæt ifølge krav 1, kendetegnet ved, at forsinkelsesmidlet har form af en semipermeabel membran, som omslutter det enzymkatalysatorholdige neutralisationsmiddel, og som består af ethylcellulose eller 10 en copolymer af acrylmethacrylsyreestere med trimethylam-moniummethacrylat eller en blanding af methacrylsyremethyl-estere og methacrylsyreethylestere.Contact lens cleaning kit according to claim 1, characterized in that the delay agent is in the form of a semi-permeable membrane which encloses the enzyme catalyst-containing neutralizing agent and consists of ethyl cellulose or a copolymer of acrylic methacrylic acid esters with trimethyl ammonium methacrylic acid and methacrylic acid methyl acrylic acid or a mixture of 15. Kontaktlinserensesæt ifølge krav 14, kendete g-15 net ved, at der er tilsat blødgørere til regulering af membranens diffusionshastighed.15. Contact lens cleaning kit according to claim 14, characterized in that plasticizers have been added to control the diffusion rate of the membrane. 16. Kontaktlinserensesæt ifølge krav 15, kendetegne t ved, at blødgørerne er 1,2-propylenglycol, polyethyl- 20 englycoler eller citronsyreestere.Contact lens cleaning kit according to claim 15, characterized in that the plasticizers are 1,2-propylene glycol, polyethylene glycols or citric acid esters. 17. Kontaktlinserensesæt ifølge et af kravene 1-5, kendetegnet ved, at overtrækket er vandopløseligt eller semipermeabelt ved en pH-værdi (mindre end 4), ved hvilken 25 hydrogenperoxidopløsningen er stabil.Contact lens cleaning kit according to one of claims 1-5, characterized in that the coating is water-soluble or semi-permeable at a pH (less than 4) at which the hydrogen peroxide solution is stable. 18. Kontaktlinserensesæt ifølge et af kravene 1-4, kendetegnet ved, at overtrækket har én eller flere perforeringer, gennem hvilke hjælpematerialerne frigives fra 30 overtrækket ved kontakt med hydrogenperoxidopløsningen, og at overtrækket er semipermeabelt eller opløseligt ved en pH-værdi på ca. 7.Contact lens cleaning kit according to one of claims 1-4, characterized in that the coating has one or more perforations through which the auxiliary materials are released from the coating upon contact with the hydrogen peroxide solution, and that the coating is semi-permeable or soluble at a pH of approx. 7th 19. Kontaktlinserensesæt ifølge et af kravene 1-4, k e n-35 detegnet ved, at enzymkatalysatoren foreligger i form af enzymkatalysatorkorn (katalyatorprill), der forekom- DK 166654 B1 mer i overtrækket sammen med hjælpematerialerne.Contact lens cleaning kit according to one of claims 1-4, characterized in that the enzyme catalyst is in the form of enzyme catalyst granules (catalyst prills) present in the coating together with the auxiliary materials. 20. Kontaktlinserensesæt ifølge krav 1, kendetegnet ved, at forsinkelsesmidlet foreligger i form af en 5 tung- til uopløselig matrix, hvor det enzymkatalysatorholdige neutralisationsmiddel er fordelt.Contact lens cleaning kit according to claim 1, characterized in that the delay agent is in the form of a 5 heavy to insoluble matrix in which the enzyme catalyst-containing neutralizing agent is distributed. 21. Kontaktlinserensesæt ifølge krav 20, kendetegnet ved, at matrixen består af en forbindelse valgt blandt 10 celluloseethere, alkalimetalsalte af alginsyre, methacryl-syrederivater, acrylsyrederivater, dextraner (molvægt 1000-75000) og polyvinylalkohol.Contact lens cleaning kit according to claim 20, characterized in that the matrix consists of a compound selected from 10 cellulose ethers, alkali metal salts of alginic acid, methacrylic acid derivatives, acrylic acid derivatives, dextrans (molecular weight 1000-75000) and polyvinyl alcohol. 22. Kontaktlinserensesæt ifølge krav 20 eller 21, k e n-15 detegnet ved, at matrixen har tabletform.The contact lens cleaning kit according to claim 20 or 21, characterized in that the matrix is of tablet form. 23. Kontaktlinserensesæt ifølge krav 1, kendetegnet ved, at forsinkelsesmidlet foreligger i fom af en af en højkoncentreret polymeropløsning støbt folie, hvori 20 det enzymkatalysatorholdige neutralisationsmiddel er indlej- ret.Contact lens cleaning kit according to claim 1, characterized in that the delay agent is in the form of a film molded from a highly concentrated polymer solution in which the enzyme catalyst-containing neutralizing agent is embedded. 24. Kontaktlinserensesæt ifølge krav 23, kendetegnet ved, at foliematerialet består af alkalimetalalgina- 25 ter, dextraner (molvægt 1000-75000) og polyvinylalkohol.Contact lens cleaning kit according to claim 23, characterized in that the foil material consists of alkali metal alginates, dextrans (molecular weight 1000-75000) and polyvinyl alcohol. 25. Kontaktlinserensesæt ifølge et af kravene 1-4, kendetegnet ved, at det enzymkatalysatorholdige neutralisationsmiddel består af overtrukne tabletter, således at 30 der ved en forsinket opløsning af overtrækket først sker frigivelse af hjælpematerialerne til ændring af pH-værdien i hydrogenperoxidopløsningen og derefter frigivelse af katalysatoren ved en pH-værdi på ca. 7.Contact lens cleaning kit according to one of claims 1 to 4, characterized in that the enzyme catalyst-containing neutralizing agent consists of coated tablets, so that, in a delayed solution of the coating, release of the auxiliary materials first changes to the pH in the hydrogen peroxide solution and the catalyst at a pH of approx. 7th 26. Kontaktlinserensesæt ifølge et af kravene 1-4, k e n- detegnet ved, at det enzymkatalysatorholdige neutra- DK 166654 B1 lisationsmiddel består af en overtrukket tablet, og at der ved en forsinket opløsning af overtrækket først sker frigivelse af enzymkatalysatoren og derefter af hj ælpematerialer-ne. 5Contact lens cleaning kit according to one of claims 1 to 4, characterized in that the enzyme catalyst-containing neutralizing agent consists of a coated tablet and that a delayed solution of the coating first releases the enzyme catalyst and then of ælpematerialer-ne. 5 27. Kontaktlinserensesæt ifølge krav 25 eller 26, kendetegnet ved, at neutralisationsmidlet har form af tolagstabletter, hvor det ene lag består af opløselige salte til neutralisation af hydrogenperoxidopløsningen, og det 10 andet lag er enzymkatalysatoen.Contact lens cleaning kit according to claim 25 or 26, characterized in that the neutralizing agent is in the form of two-layer tablets, one layer consisting of soluble salts for neutralizing the hydrogen peroxide solution and the other layer being the enzyme catalyst. 28. Kontaktlinserensesæt ifølge et af kravene 1-4, kendetegnet ved, at neutralisationsmidlet foreligger som basisk gel i overtrækket, der er opløselig ved en pH- 15 værdi <7.Contact lens cleaning kit according to one of claims 1-4, characterized in that the neutralizing agent is present as a basic gel in the coating which is soluble at a pH <7. 29. Kontaktlinserensesæt ifølge et af kravene 1-4, kendetegnet ved, at enzymkatalysatoren foreligger som viskos opløsning, der omgiver hjælpematerialerne i overtræk- 20 ket.Contact lens cleaning kit according to one of claims 1-4, characterized in that the enzyme catalyst is present as a viscous solution which surrounds the auxiliary materials in the coating. 30. Kontaktlinserensesæt ifølge et af kravene 1-4, kendetegnet ved, at neutralisationsmidlet er omgivet af en semipermeabel membran, som gennemtrænges af vand til 25 opløsning af hjælpematerialerne i det indre, og hvorfra de opløste salte trænger ud som følge af det osmotiske tryk.Contact lens cleaning kit according to one of claims 1-4, characterized in that the neutralizing agent is surrounded by a semipermeable membrane which is permeated by water to dissolve the auxiliary materials in the interior and from which the dissolved salts enter as a result of the osmotic pressure. 31. Kontaktlinserensesæt ifølge krav 30, kendetegnet ved, at den semipermeable membran har en eller flere 30 perforeringer.Contact lens cleaning kit according to claim 30, characterized in that the semi-permeable membrane has one or more perforations. 32. Kontaktlinserensesæt ifølge krav 31, kendetegnet ved, at den semipermeable membran kan nedbrydes af det osmotiske tryk. 35Contact lens cleaning kit according to claim 31, characterized in that the semipermeable membrane can be degraded by the osmotic pressure. 35 33. Kontaktlinserensesæt ifølge krav 17 og et af kravene DK 166654 B1 30-32, kendetegnet ved, at enzymkatalysatoren er omgivet af den semipermeable membran, på hvis yderside hjælpematerialerne ligger, og at det ved pH-værdien (<4) i den stabile hydrogenperoxidopløsning vandopløselige eller semi-5 permeable overtræk omgiver hjælpematerialerne og den semipermeable membran, som indeslutter enzymkatalysatoren.Contact lens cleaning kit according to claim 17 and one of claims DK 166654 B1 30-32, characterized in that the enzyme catalyst is surrounded by the semipermeable membrane on which the auxiliary materials lie, and that at the pH (<4) in the stable hydrogen peroxide solution water-soluble or semi-permeable coatings surround the auxiliary materials and the semipermeable membrane enclosing the enzyme catalyst. 34. Kontaktlinserensesæt ifølge krav 17 og et af kravene 30-32, kendetegnet ved, at enzymkatalysatoren 10 ligger på ydersiden af membranen, som omgiver hjælpematerialerne, og at det vandopløselige eller semipermeable overtræk omgiver enzymkatalysatoren og membranen, som indeslutter hj ælpematerialerne.Contact lens cleaning kit according to claim 17 and one of claims 30-32, characterized in that the enzyme catalyst 10 is located on the outside of the membrane surrounding the auxiliary materials and that the water-soluble or semipermeable coating surrounds the enzyme catalyst and the membrane which encloses the auxiliary materials. 35. Kontaktlinserensesæt ifølge krav 1, kendeteg net ved, at forsinkelsesmidlet har form af partikelformige bærelegemer, hvortil den hydrogenperoxidsønderdelende enzymkatalysator er immobiliseret.Contact lens cleaning kit according to claim 1, characterized in that the delay agent is in the form of particulate support bodies to which the hydrogen peroxide decomposing enzyme catalyst is immobilized. 36. Kontaktlinserensesæt ifølge krav 1, kendeteg net ved, at enzymkatalysatoren er catalase.The contact lens cleaning kit of claim 1, characterized in that the enzyme catalyst is catalase. 37. Kontaktlinserensesæt ifølge krav 35 og 36, k e n-detegnet ved, at bærelegemerne består af acrylhar- 25 piks, og at enzymkatalysatoren (catalase, peroxidase) er bundet over reaktive oxirangrupper på bærelegemet.37. Contact lens cleaning kit according to claims 35 and 36, characterized in that the support members consist of acrylic resin and that the enzyme catalyst (catalase, peroxidase) is bonded over reactive oxirane groups on the support body. 38. Kontaktlinserensesaæt ifølge krav 35 eller 37, kendetegnet ved, at bærelegemerne er anbragt i en be- 30 holderdel, som kan frigøres fra behandlingsbeholderen, og er adskilt fra beholderens indre, som indeholder den hydr-ogenperoxidholdige behandlingsopløsning, ved hjælp af et permeabelt indifferent sivæv.The contact lens cleaning kit according to claim 35 or 37, characterized in that the support bodies are disposed in a container portion which is detachable from the treatment container and is separated from the interior of the container containing the hydr and peroxide-containing treatment solution by a permeable inertifier. phloem. 39. Kontaklinserensesæt ifølge krav 38, kendeteg net ved, at beholderdelen, som kan frigøres, er udformet DK 166654 Bl som afskrueligt beholderlåg eller beholderbund.The contact lens cleaning kit according to claim 38, characterized in that the detachable container part is configured DK 166654 B1 as a removable container lid or container bottom. 40. Kontaktlinserensesæt ifølge et af kravene 1-39, kendetegnet ved, at sønderdelingen af hydrogen- 5 peroxidet indiceres ved hjælp af en farveindikator.Contact lens cleaning kit according to one of claims 1-39, characterized in that the decomposition of the hydrogen peroxide is indicated by a color indicator. 41. kontaktlinserensesæt ifølge krav 3, kendetegnet ved, at hjælpematerialerne er puffere på basis af NaH2PC>4, Na2HP04 og NaCl, filmdannende materialer og fug- 10 temidler.Contact lens cleaning kit according to claim 3, characterized in that the auxiliary materials are buffers based on NaH2PC> 4, Na2HPO4 and NaCl, film forming materials and wetting agents.
DK431286A 1985-09-11 1986-09-10 THE CONTACT LENS CLEANING SITE WITH TWO TREATMENTS DK166654B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19853532433 DE3532433A1 (en) 1985-09-11 1985-09-11 Contact-lens care set
DE3532433 1985-09-11

Publications (3)

Publication Number Publication Date
DK431286D0 DK431286D0 (en) 1986-09-10
DK431286A DK431286A (en) 1987-03-12
DK166654B1 true DK166654B1 (en) 1993-06-28

Family

ID=6280690

Family Applications (1)

Application Number Title Priority Date Filing Date
DK431286A DK166654B1 (en) 1985-09-11 1986-09-10 THE CONTACT LENS CLEANING SITE WITH TWO TREATMENTS

Country Status (6)

Country Link
AU (1) AU605464B2 (en)
DE (1) DE3532433A1 (en)
DK (1) DK166654B1 (en)
ES (1) ES2002483A6 (en)
FI (1) FI84521C (en)
NO (1) NO170308C (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4829001A (en) * 1985-11-08 1989-05-09 Minnesota Mining And Manufacturing Company Enzymatic neutralization of hydrogen peroxide
US4757014A (en) * 1985-11-08 1988-07-12 Minnesota Mining And Manufacturing Company Immobilization of biologically active protein on a polymeric fibrous support
JP2625697B2 (en) * 1987-02-06 1997-07-02 三菱瓦斯化学株式会社 Contact lens treatment method
US5306352A (en) * 1989-12-28 1994-04-26 Ciba-Geigy Corporation Peroxide disinfection method
ES2020888A6 (en) * 1990-06-11 1991-10-01 Disop Sa Method for preserving contact lenses in one step.
DE19729831C2 (en) * 1997-07-11 2000-07-27 Albert Sturm Contact lens care products

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282702A (en) * 1963-07-16 1966-11-01 Union Carbide Corp Process for removing hydrogen peroxide from liquids
ATE30511T1 (en) * 1981-12-21 1987-11-15 Titmus Eurocon Kontaktlinsen PROCEDURE FOR DISINFECTING AND CLEANING CONTACT LENSES.
FR2544880B1 (en) * 1983-04-20 1986-08-29 Pos Lab PROCESS FOR THE CLEANING AND DECONTAMINATION OF CONTACT LENSES AND COMPOSITION FOR ITS IMPLEMENTATION
DE3329922A1 (en) * 1983-08-19 1985-02-28 Fa. Carl Zeiss, 7920 Heidenheim CLEANING AND DISINFECTING SYSTEM FOR HARD AND SOFT CONTACT LENSES
AU573247B2 (en) * 1983-08-25 1988-06-02 Advanced Medical Optics, Inc. Contact lens disinfection

Also Published As

Publication number Publication date
FI863207A0 (en) 1986-08-06
DK431286A (en) 1987-03-12
NO863126D0 (en) 1986-08-04
AU605464B2 (en) 1991-01-17
ES2002483A6 (en) 1988-08-16
NO863126L (en) 1987-03-12
AU6065286A (en) 1987-03-12
FI84521B (en) 1991-08-30
NO170308B (en) 1992-06-22
FI863207A (en) 1987-03-12
NO170308C (en) 1992-09-30
DK431286D0 (en) 1986-09-10
FI84521C (en) 1992-07-07
DE3532433A1 (en) 1987-03-26

Similar Documents

Publication Publication Date Title
US5011661A (en) Contact lens care set
JP6568519B2 (en) Medical covering device
JP5354502B2 (en) Hydrogen peroxide delivery system
FI77575B (en) STERILIZERINGBEHANDLING MED VAETESUPEROXID AV ARTIKLAR OCH NEUTRALISERING AV DENNAS RESTMAENGDER.
ES2343675T3 (en) ANTIMICROBIAL MATERIALS STABILIZED AGAINST LIGHT.
US20150306064A1 (en) Wound Care Products with Peracid Compositions
JPH10509052A (en) Hydrogel patch
ES2753125T3 (en) Wound care products with peracid compositions
DK166654B1 (en) THE CONTACT LENS CLEANING SITE WITH TWO TREATMENTS
US20100062043A1 (en) Methods, Systems and Devices for Administration of Chlorine Dioxide
US20060281165A1 (en) Method for stabilization of enzymes during exposure to sterilizing radation
US11213604B2 (en) Composition for dressing cutaneous lesions and manufacturing method thereof
JPS6263916A (en) Contact lens mending agent
CA1297403C (en) Contact-lens care set
JPH04506159A (en) Composition
US5645848A (en) Controlled release composition for active substances into an aqueous medium
CN109620842B (en) Cross-linked polyvinylpyrrolidone and iodine complex, and preparation method and application thereof
CN108721328B (en) Chitosan iodine biological material and preparation method thereof
JP3189131B2 (en) How to clean and disinfect contact lenses
KR960002180B1 (en) Oral osmotic system for metoprolol having a specific composition
RU2218185C2 (en) Agent &#34;delansal&#34; for disinfecting and sterilization of medical-destination materials, tools, and equipment and a method for preparation thereof
RU2055583C1 (en) Antiseptic agent
Deepalakshmi Spectrophotometric Analysis and Evaluation of Sustained Release of 2% Chlorhexidine from a Polymeric Medium (PVA & PVA+ AgNPs) and Its Efficacy against E. Faecalis: An Invitro Study
SI8810221B (en) Process for preparing of oral thepapeutic system

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PPF Opposition filed
PPF Opposition filed
PUG Patent revoked